'Neglected' public sector unlikely to benefit from Indian procurement plan
This article was originally published in Scrip
Executive Summary
India's renewed policy to procure 103 drugs from Central Public Sector Enterprises (CPSEs), few of which are in good health, is unlikely dramatically to revive the fortunes of these firms, according to a clutch of industry experts.